FIG. 1.
Schematic illustrations of the HTLV-1 proviral genome (A) and the p13II transcript (B), highlighting the mutation (CATG → AGAT) created for the mutant molecular clone (i.e., ACH → ACH.p13) that selectively ablates p13II expression. The mutation also generates a unique BglII restriction site. LTR, long terminal repeat.
